Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Immunotherapy entities : Novartis ag save search
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.46%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.49%
H: 0.6%
C: -0.83%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.15%
H: 1.88%
C: -1.17%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.24%
H: 1.43%
C: 1.43%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.32%
H: 0.93%
C: 0.38%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.98%
C: 0.72%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.68%
H: 0.87%
C: 0.1%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.32%
H: 0.44%
C: 0.26%
america cancer immunotherapy market
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.67%
H: 1.17%
C: 0.85%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 1.16%
H: 0.14%
C: -1.89%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
cancer global immunotherapy market
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -2.51%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.38%
H: 1.09%
C: 0.87%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -0.68%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.29%
H: 0.45%
C: -0.32%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.65%
H: 0.83%
C: -0.03%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.49%
H: 1.67%
C: 0.64%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: -0.06%
research global immunotherapy report cancer growth market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 3 d | $10.22 -7.68% -8.32% 400K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6917 -3.25% -3.35% 830K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.34%
H: 1.72%
C: 0.95%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market treatment
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-04-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.45%
H: 0.46%
C: 0.19%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -1.11%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.39%
H: 0.53%
C: 0.44%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.27%
H: 2.95%
C: 1.12%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.05%
H: 2.52%
C: 2.49%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.35%
H: 2.64%
C: 2.45%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.29%
H: 1.42%
C: 0.98%
immunotherapy cancer market
Drugs for Immunotherapy Global Market Report 2022
Published: 2022-03-25 (Crawled : 18:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -6.55%
H: 7.81%
C: 7.56%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.28%
H: 1.09%
C: 0.18%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.58%
H: 1.16%
C: 0.23%
immunotherapy report market drug
Cellular Immunotherapy Global Market Report 2022
Published: 2022-03-25 (Crawled : 14:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
immunotherapy report market
Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential
Published: 2022-01-24 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: -1.88%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -3.71%
H: 0.66%
C: 0.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.45%
H: 0.18%
C: -0.02%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.05%
H: 1.59%
C: -3.17%
EXAS | $63.45 0.36% 0.36% 1.6M
|
Health Technology
|
| O: -2.0%
H: 3.27%
C: 2.91%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -2.95%
H: 2.45%
C: 1.98%
immunotherapy potential therapy cancer market
Novartis strengthens immunotherapy pipeline with option, collaboration and license agreement with BeiGene for TIGIT inhibitor ociperlimab
Published: 2021-12-20 (Crawled : 23:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.03%
H: 0.24%
C: -0.15%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 8.83%
H: 0.11%
C: -4.16%
novartis license immunotherapy therapy collaboration
Immunotherapy Drugs Market Size to Reach Revenues of USD 326.36 Billion by 2026 - Arizton
Published: 2021-10-12 (Crawled : 17:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.11%
H: 0.34%
C: -0.33%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.44%
H: 0.16%
C: -0.82%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.72%
H: 0.1%
C: -0.06%
immunotherapy therapy drug
Global Leukemia Therapeutics Markets, 2016-2020 & 2021-2026 - Chemotherapy, Stem Cell Transplantation, Immunotherapy, Targeted Therapy, & Others
Published: 2021-04-21 (Crawled : 17:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.56%
H: 0.72%
C: 0.38%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.5%
H: 0.76%
C: -0.32%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.67%
H: 0.56%
C: -0.3%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.7%
H: 1.5%
C: 0.92%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 1.24%
H: 0.48%
C: 0.36%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.49%
H: 0.23%
C: -0.63%
immunotherapy stem cell therapy leukemia
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.